Homburg Saar, Germany

Sara Menina

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sara Menina: Innovator in Intracellular Drug Targeting

Introduction

Sara Menina is a prominent inventor based in Homburg Saar, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of carrier systems for drug targeting. Her innovative work aims to enhance the efficacy of drug delivery systems, making them more effective in treating various diseases.

Latest Patents

Sara Menina holds a patent for her invention titled "Methods and compositions of carrier systems for the purpose of intracellular drug targeting." This patent describes a carrier system that includes a pathogen entry protein or fragment that specifically binds to a molecule on the surface of a mammalian target cell. The carrier is covalently linked to the surface of the carrier and at least one hydrophilic antipathogenic agent. The invention also outlines a method for manufacturing this carrier system and its application as a medicament.

Career Highlights

Sara Menina is associated with Helmholtz-Zentrum für Infektionsforschung GmbH, where she conducts her research and development activities. Her work is pivotal in advancing the understanding of drug delivery mechanisms and improving therapeutic outcomes for patients.

Collaborations

Sara collaborates with esteemed colleagues, including Claus-Michael Lehr and Hagar Ibrahim Labouta. These partnerships enhance her research capabilities and contribute to the innovative solutions she develops in her field.

Conclusion

Sara Menina is a trailblazer in the realm of intracellular drug targeting, with her patent reflecting her commitment to improving healthcare through innovative solutions. Her work continues to inspire advancements in pharmaceutical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…